Volume 27, Number 1—January 2021
Research
Human Diversity of Killer Cell Immunoglobulin-Like Receptors and Human Leukocyte Antigen Class I Alleles and Ebola Virus Disease Outcomes
Table 3
Term | p ≠ 0 | β estimate | SE | Best model |
---|---|---|---|---|
2DL2 | 88.1 | 1.02 | 0.54 | 1.18 |
2DL5 | 59.1 | −0.43 | 0.46 | −0.65 |
KIR2DS4.0003 | 16.6 | −0.08 | 0.20 | (...) |
HLA-B-Bw4-Thr | 45.8 | −0.38 | 0.48 | (...) |
HLA-B-Bw4-Ile | 45.1 | 0.27 | 0.34 | (...) |
*Intercepts have been omitted for interpretation purposes. p ≠ 0 indicates the probability that the coefficient for a given predictor is not zero. Ellipses (...) represent predictors that were not present in the best model.
Page created: October 16, 2020
Page updated: December 21, 2020
Page reviewed: December 21, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.